Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000020

COO and SVP, R&D acquired 44,871 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · COO and SVP, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-11 Exercise or conversion : show line 1 in the form +44,871 $0.63 $28,269 102,605 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-11 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −44,871 0 D
Loading xslF345X03/wf-form4_161351699826212.xml…